Pre- and post-treatment circulating tumor cell counts (CTCc) and overall survival (OS) in castration-resistant prostate cancer (CRPC): The Royal Marsden Hospital (RMH) experience

Authors :: David Olmos
Craig P. Carden
Peter C.C. Fong
J.S. de Bono
A. Reid
Chris Parker
J.E. Ang
H.-T. Arkenau
Gerhardt Attard
Ioanna Ledaki
Source :: Journal of Clinical Oncology. 26:5072-5072
Publication Year :: 2008
Publisher :: American Society of Clinical Oncology (ASCO), 2008.
Abstract: 5072 Background: Recent studies have shown that CTCc predict OS in patients (pts) with CRPC. Methods: CTC were collected at baseline and after 1 and 2 cycles of treatment in CPRC pts starting a new...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Castration resistant
medicine.disease
Surgery
Prostate cancer
Circulating tumor cell
Internal medicine
medicine
Overall survival
In patient
business
Pre and post

Full Text Access

Tools